Eli Lilly (LLY)

The drugmaker continues to face headwinds.

CVS Health (NYSE:CVS) reported second-quarter results that exceeded its expectations, citing earnings growth across all operating segments and raising its full-year outlook for adjusted earnings per share and operating cash flow. Chair and Chief Executive Officer David Joyner said the company gener

Global Abemaciclib Market to Reach USD 3.18 Billion by 2034, Growing at 9.7% CAGR According to the latest market intelligence from Intel Market Research, t

Global pharmaceutical company Eli Lilly (NYSE:LLY) reported Q2 CY2026 results topping the market’s revenue expectations, with sales up 47.7% year on year to ...

Demand for the healthcare leader's weight-loss drugs continues to rise.

XLV's lower costs and broader holdings delivered 30% more growth over five years, while BBH's concentrated biotech focus offers higher single-stock upside.

On Aug. 5, 2026, new highs across major indexes reflect renewed confidence in global trade as investor confidence starts to return.

What Happened? Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) jumped 2.5% in the morning session after the company delivered a massive "beat an...

Hims & Hers Health shares have rallied despite an FTC lawsuit over data sharing and billing practices, as weight-loss drug partnerships and Wall Street's cautious Hold rating shape the stock's outlook ahead of Q2 earnings.

Eli Lilly (LLY) beat Q2 earnings expectations & raised 2026 guidance as Mounjaro and Zepbound drove $22.97B in revenue. Read more.

Stocks mixed as Nasdaq falls 100 points, Dow rises .79%. Eli Lilly beats earnings estimates, Digital Turbine surges 43%, oil down .4%, gold up 2.5%

CVS Health beats Q2 earnings expectations and hikes FY26 guidance, but shares fall on profit-taking. Get the full financial breakdown.

Eli Lilly stock jumped Wednesday on a solid beat-and-raise thanks to its GLP-1 drugs, treatments for diabetes and obesity.

Global pharmaceutical company Eli Lilly (NYSE:LLY) reported Q2 CY2026 results exceeding the market’s revenue expectations, with sales up 47.7% year on year t...

Animal health company Elanco (NYSE:ELAN) reported revenue ahead of Wall Street’s expectations in Q2 CY2026, with sales up 10.2% year on year to $1.37 billion...

U.S. stock futures up, Eli Lilly, AMD, Disney, SpaceX and SanDisk expected to release earnings. SpaceX beats estimates, shares down 7.5%.

Eli Lilly (NYSE:LLY) has outperformed the market over the past 20 years by 6.87% on an annualized basis producing an average annual return of 16.31%. Currently, Eli Lilly has a market capitalization of $1.01 trillion.

Earnings coming Wed with varying volatility levels. Benzinga Pro selected list incl. relatively muted setups to double-digit swings. Top pick Eli Lilly.

Eli Lilly's key catalyst for 2027 could positively affect price action sooner than you think.

With volatility heating up, some investors may prefer the straightforward approach of the Vanguard Mega Cap Growth ETF.

Eli Lilly investors may be eyeing potential gains from the company’s annual dividend yield of 0.62% ($6.92 a year).